Analystreport

Gemphire Therapeutics (NASDAQ: GEMP) is now covered by analysts at Raymond James. They set an "outperform" rating on the stock.

GEMPHIRE THERAPEUTICS INC COMMON  (GEMP) 
Last gemphire therapeutics inc common earnings: 5/9 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.gemphire.com